Xconomy

FEBRUARY 21, 2020

The price of insulin, a life-saving treatment discovered a century ago, has been a flashpoint amid the broader drug pricing debate. The FDA is trying to tame high insulin prices by encouraging price competition. The FDA has historically regarded insulin as a drug.

Pricing 79

Pricing Competition Product Marketing 79

Xconomy

MAY 24, 2019

Patients, doctors, family members, and drug-price watchdogs continued to wait for the expected approval of Zolgensma , a Novartis (NYSE: NVS ) gene therapy for the rare inherited disease spinal muscular atrophy. Originally developed at a children’s hospital in Ohio , Zolgensma will be a litmus test for the nascent field.

Pricing 86

Pricing Marketing Develop Development 86

Xconomy

MAY 9, 2019

billion in new capital late Thursday as it priced an initial public offering that set its market capitalization at $82.4 That price is near the lowest end of the range Uber set at $44 to $50 in the amended prospectus it filed on April 26. Ride-hailing giant Uber secured $8.1

Marketing 88

Marketing Pricing News Capital 88

Xconomy

NOVEMBER 20, 2019

Drug pricing debates and uncertainty associated with Brexit are the issues most likely to keep biopharmaceutical executives awake at night. In turn, pricing pressure is also a concern as corporates and investors plan for the year ahead,”. Nevertheless, senior figures remain optimistic about the industry’s prospects in 2020.

Pricing 78

Pricing Invest Develop Development 78

Xconomy

DECEMBER 14, 2018

Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used insulin. But the university also allowed them to patent the improvements they made, which enabled them to slap higher prices on each new version. to offer competitive pricing pressure.

Patents 77

Patents Pricing Competition San Diego 77

Xconomy

DECEMBER 13, 2019

If you’re keeping track, FDA drug approvals have been on a tear in the past month with several decisions coming well ahead of their targeted dates. And then there’s Sarepta Therapeutics. Late Thursday, the FDA announced approval of the Cambridge, MA, biotech’s drug for Duchenne muscular dystrophy in patients who have a specific mutation.

Pricing 49

Pricing Southern California USC San Diego 49

Xconomy

MAY 2, 2019

Beyond Meat priced its IPO Wednesday evening at $25 per share, which was the high end of its revised range. million shares at that price. The food technology company’s upsized IPO has raised $241 million to finance plans to bring its plant-based “meat” to more grocery stores and restaurants across the country.

El Segundo 82

El Segundo Pricing Technology Venture Capital 82

Xconomy

JUNE 4, 2018

Inventory management is crucial to operating a successful retail operation. And as hard as it may be to believe, retailers “don’t really know what’s on the shelves,” says Sarjoun Skaff, founder and CTO of Bossa Nova Robotics.

Artificial Inteligence 69

Artificial Inteligence Pricing Product San Diego 69

Xconomy

MARCH 9, 2018

If a shopper interacts with technology in a typical grocery store, it’s usually at the very end—as they are paying for their items. That could be about to change, though.

Pricing 69

Pricing Advertising Ideas Artificial Inteligence 69

Xconomy

JANUARY 25, 2019

Where the business is based would seem to have an impact on how much money it can raise: If you’re a San Francisco startup, you’d presumably get more money to cover the price of those high-salary engineers and that expensive office. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Startup 101

Startup Pricing Software Capital 101

Xconomy

JULY 25, 2019

On Wednesday evening, Castle priced its offering of 4 million shares at $16 apiece, which was the high end of its targeted price range. Castle Biosciences is joining the public markets through a $64 million IPO that will support cancer tests that help doctors make treatment decisions. million shares in the range of $14 to $16 each.

Training 60

Training Pricing Activity Help 60

Xconomy

MAY 1, 2019

Amazon’s stock price rose by 2.5 percent the day after it announced financial results and changes to the Prime program, while rivals Walmart (NYSE: WMT ) and Target (NYSE: TGT saw their stock prices. The Seattle e-commerce giant told analysts the move would cost around $800 million but that didn’t appear to concern investors.

Commerce 84

Commerce Pricing Startup Demand 84

Xconomy

MAY 17, 2019

During his tenure as FDA commissioner, Scott Gottlieb often spoke about generics as a market force that could help tame climbing drug prices. Generic drugs are supposed to give consumers more choices and a counterweight to more costly branded medications. But such tools only work when companies play fair.

Pricing 79

Pricing Competition Tool Marketing 79

Xconomy

JULY 12, 2016

— 5D Robotics , founded in 2009 in Carlsbad, CA, (about 30 miles north of San Diego), has developed a device that integrates GPS, inertial guidance, optical positioning, and other technologies. SlantRange, a San Diego company founded almost three years ago, is a drone-related startup already generating sales.

San Diego 40

San Diego Seed Funding Guide Technology 40

Xconomy

JANUARY 29, 2019

Previous investors Silverton Partners, Female Founders Fund, and Lakehouse Ventures also participated in Billie’s new round, which the company says will be used for additional product development. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Product 90

Product Services Invest Pricing 90

Xconomy

APRIL 23, 2019

After a breakout year in 2017, the blockchain sector suffered a series of blows in 2018, from crashing cryptocurrency prices to increased regulatory scrutiny of crypto ventures and deepening skepticism about whether the technology was actually useful.

Report 98

Report Pricing Organization Technology 98

Xconomy

JUNE 12, 2019

Sunnyvale, CA-based CrowdStrike (NASDAQ: CRWD ) priced 18 million shares of common stock at $34 on Tuesday. Wednesday, and reached a near-doubling of the company’s IPO price before settling down to close at $58 for a first-day bump of more than 70 percent. That close pegged CrowdStrike’s market capitalization at $11.4

Pricing 54

Pricing Capital Marketing Venture Capital 54

Xconomy

SEPTEMBER 13, 2016

MedCrypt, a healthtech cybersecurity startup founded near San Diego, has raised $750,000 in a seed financing round led by Safeguard Scientifics (NYSE: SFE ), a private equity fund in suburban Philadelphia that invests in healthcare, fintech, and digital media. Jude’s stock price.

San Diego 40

San Diego Startup Software Capital 40

Xconomy

APRIL 5, 2019

Perhaps it’s drug prices. Or maybe it’s regulation. While Gottlieb remained mindful of the FDA’s oversight role, he also tried to streamline the process for reviewing new drugs and medical devices. On numerous occasions, Gottlieb argued that generics would. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 69

Pricing San Diego Research Blogging 69

Xconomy

MAY 10, 2019

With Uber’s long-awaited IPO, Facebook’s mounting controversies, and ongoing debates over drug pricing and safety issues, come a great responsibility. A big story in the innovation community now is about the ethics and regulation of tech and life sciences.

Pricing 75

Pricing Entrepreneur Venture Capital CalTech 75

Xconomy

NOVEMBER 1, 2018

IBM’s planned $34 billion deal to acquire open-source software maker Red Hat is a hefty price to pay to give its cloud computing business a shot in the arm. In some ways, the biggest software acquisition of all time could be a yawner.

IBM 100

IBM IBM Cloud Computing Google 100

Xconomy

APRIL 6, 2018

There were plenty of policy and drug-price headlines, Read more » Reprints | Share: The FDA didn’t smile upon a big submission of depression studies from Alkermes, while those fighting liver disease got a mixed slate of data as a big medical conference looms.

Study 55

Study Pricing Conference Marketing 55

Xconomy

SEPTEMBER 1, 2017

billion, the price Gilead Sciences is paying for Kite Pharma and its cancer-fighting cell therapy pipeline. The far-out idea of reprogramming a patient’s immune cells to fight cancer, known as CAR-T, entered the mainstream this week, and two numbers highlight the tale. The first is $11.9

Pricing 74

Pricing Ideas San Diego Study 74

Xconomy

OCTOBER 10, 2018

San Francisco-based Anaplan , one of five companies planning to close initial public offerings this week, raised the expected price range for its shares in an SEC filing Wednesday, signaling an IPO that could be richer than it had anticipated. If the shares price at $16—the midpoint of the new range—Anaplan.

Pricing 46

Pricing Software Venture Capital Company 46

Xconomy

APRIL 19, 2017

At the same time, government policy issues ranging from drug pricing to education to immigration have never been more urgently tied to business concerns. To help our readers sort through an increasingly complex. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Education 79

Education News Pricing Technology 79

Xconomy

JUNE 22, 2018

Others that pushed their IPOs through couldn’t sell shares at the price they wanted. A total of 93 IPOs have priced as of Thursday, up 36.8 percent compared to the same time last year, according to Renaissance Capital. Seven biotech IPOs priced just this week. This year, the IPO window is wide open.

Pricing 49

Pricing Capital Draper San Diego 49

Xconomy

JULY 31, 2018

Co-founder Maria Markina says her New York-based startup gives women the convenience of a subscription service but at lower prices compared to other similar services. We’re not sacrificing quality, but we are bringing the price [down] so that many more women can afford” to purchase the subscription, Markina says.

Commerce 52

Commerce Pricing Organization Funding 52

Xconomy

NOVEMBER 10, 2017

Meanwhile, Ohio voters rejected the latest legislative attempt to curb drug prices, Maine residents supported Medicaid expansion, and patient advocates campaigned for changes to. And investors of Sprout Pharmaceuticals reclaimed, for a pittance, a drug they once sold to Valeant Pharmaceuticals for $1 billion.

Pricing 52

Pricing San Diego Venture Capital Blogging 52

Xconomy

MARCH 2, 2017

billion and sent shares up more than 50 percent above the initial offering price during the first day of trading today. Snap (NYSE: SNAP ) priced its IPO shares at $17, higher than the $14 to $16 range it estimated in an SEC filing last month.

Social Media 40

Social Media Venice Pricing Media 40

Xconomy

AUGUST 16, 2017

Private equity investors have more capital at their disposal than at any time in more than a decade, which could boost prices for companies seeking acquisitions. As of Aug. 1, private equity firms in North America and Europe had secured $212.6

Equity 69

Equity Pricing Acquisition Report 69

Xconomy

JUNE 11, 2018

As of this writing, it was trading at nearly $92 per share, up more than 5 percent from Friday’s closing price. The news sent PTC’s stock (NASDAQ: PTC ) to a record high for the company, according to Yahoo Finance data. Read more » Reprints | Share:

Yahoo 45

Yahoo Writing News Pricing 45

Xconomy

JULY 24, 2019

It’s a boon for the South San Francisco startup founded in 2014, but not an unusual haul for competitors in the same field, where the tantalizing promise of a simple test to find cancer sooner, when it is much easier to treat, has emerged from advances in DNA sequencing, sophisticated data crunching, and the understanding of cancer biology.

Funding 90

Funding Startup Artificial Inteligence Venture Capital 90

Xconomy

AUGUST 30, 2019

You might be camping, barbecuing, or sleeping on Monday. It’s Labor Day, after all. But in Paris, this cardiologist will be in a conference center, walking an audience through a slide deck packed with Phase 3 data for a new cholesterol-lowering drug, inclisiran. Inclisiran’s owner, the Medicines Co.,

Slides 80

Slides Conference Venture Capital San Diego 80

Xconomy

APRIL 9, 2018

View the Slideshow With the first quarter in the books, it’s time to step back and lay out Xconomy’s editorial map for the rest of the year.

News 86

News Education Conference Report 86

Xconomy

SEPTEMBER 16, 2016

And the drug-price frenzy continued, with Senators Tammy Baldwin and John McCain introducing a new bill to combat price hikes and Mylan CEO Heather Bresch set to testify on Capitol Hill about the EpiPen price increases next week.

Research 40

Research Pricing News Report 40

Xconomy

SEPTEMBER 21, 2018

Convoy , an online marketplace that connects shippers with freight truck fleets and independent drivers, announced today it raised $185 million in a Series C fundraising round led by CapitalG, the growth equity investment fund of Alphabet, Google’s parent company. regions, CEO Dan Lewis says.

Equity 54

Equity Networking Funding Artificial Inteligence 54

Xconomy

NOVEMBER 4, 2016

Its owner Pfizer (NYSE: PFE ) shelved it this week , citing poor Phase 3 data and pricing pressures on the two approved PCSK9 drugs. . —The new wave of so-called PCSK9 drugs to treat high cholesterol, once expected to flood the market , have barely caused a ripple. One latecomer, bococizumab, won’t even reach approval.

Research 40

Research Report Pricing Journal 40